Morgan Stanley
ELAT

Morgan Stanley’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Morgan Stanley’s Portfolio ELAT Stock Details ELAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,767
Closed -$347K – 7972
2022
Q4 		$347K Sell
17,767
-139,429
-89% -$2.8M ﹤0.01% 5420
2022
Q3 		$3.22M Buy
157,196
+48,867
+45% +$1.4M ﹤0.01% 4045
2022
Q2 		$3.46M Buy
108,329
+105,746
+4,094% +$3.99M ﹤0.01% 4089
2022
Q1 		$106K Sell
2,583
-24,834
-91% -$1.04M ﹤0.01% 6270
2021
Q4 		$1.22M Buy
27,417
+21,202
+341% +$1.02M ﹤0.01% 4936
2021
Q3 		$309K Buy
6,215
+628
+11% +$32.7K ﹤0.01% 5768
2021
Q2 		$297K Buy
5,587
+654
+13% +$32.8K ﹤0.01% 5815
2021
Q1 		$228K Sell
4,933
-37,855
-88% -$1.82M ﹤0.01% 5587
2020
Q4 		$2.04M Buy
42,788
+38,098
+812% +$1.82M ﹤0.01% 4141
2020
Q3 		$208K Sell
4,690
-546
-10% -$23K ﹤0.01% 5093
2020
Q2 		$197K Buy
5,236
+1,458
+39% +$58.9K ﹤0.01% 5085
2020
Q1 		$159K Buy
+3,778
New +$181K ﹤0.01% 4968

Morgan Stanley's ELAT Position: Q1 2023 in Review

Morgan Stanley sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 17,767 shares — an estimated $347K sold.

Morgan Stanley first reported a position in ELAT in Q1 2020 and held it in 12 quarters. The position peaked at $3.46M in Q2 2022. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

  • Morgan Stanley reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 17,767 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $347K.
  • Morgan Stanley first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 12 quarters.
  • Morgan Stanley's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $3.46M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.